Phase II Trial of Pazopanib (GW786034) in Pre-Treated and Untreated Metastatic Melanoma Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00861913

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:07.636801+00:00

Published At

2014-01-21T00:00:00+00:00

Record Updated At

2018-10-16

Results Posted At

2014-01-21

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Recurrent Melanoma", "Stage IV Cutaneous Melanoma AJCC v6 and v7"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-10-16"

protocolSection.identificationModule.nctId

"NCT00861913"

protocolSection.identificationModule.officialTitle

"Phase II Trial of Pazopanib (GW786034) in Pre-Treated and Untreated Metastatic Melanoma Patients"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2014-01-21"

Study condition terms

• Recurrent Melanoma (protocolSection.conditionsModule.conditions)
• Stage IV Cutaneous Melanoma AJCC v6 and v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.